The global anti-biofilm wound dressing market was valued at USD 575.4 million in 2019 and is expected to grow at a CAGR of 9.2% during the forecast period. Increasing chronic diseases i.e. diabetes, cancer, along with increasing cases of burns, sports injury, street mishaps are the key factors responsible for the growth of the market. Moreover, the patients with various disorders are increasing as due to COVID-19 such as the eating habits, sedentary, changes in lifestyle is affecting badly which is affecting at human’s health which leads to growth in chronic diseases such as cancer, diabetes which is fueling the global market.
Moreover, the multidrug resistance of susceptible pathogens, along with the lack of success in developing newer anti-microbials, has resulted in a looming crisis. Anti-biofilms are the natural substrate which prevents the biofilm formation by the mechanism of repressing the microorganism adhesions & preventing the formation of polymer matrix through ECM generation. These agents are widely used in dressing purposes as it inhibits the microbial contamination which is beneficial for minimizing further infection. The major clinical challenges in the treatment of wounds are the management of wound exudate & the effective treatment of biofilm-related infections.
Know more about this report: request for sample pages
Rising cases of burns, trauma, and road accidents globally is witnessed to fuel the global market. As per the World Health Organization (WHO) in 2018, around 1,000,000 individuals in India suffered from severe & moderate burn per year. Additionally, according to the NCBI, in 2017, countries i.e. Finland, Bulgaria, the Netherlands, South Korea, China, and the U.K. has recorded an increase in the cases of burn wounds.
Meanwhile, as per the American Association for the Surgery of Trauma (AAST), in 2017, more than 1.2 million people died worldwide, & by road mishaps more than 3,242 deaths every day. Road mishaps mostly occurred at middle or lower-income level countries. Biomaterials & skin ingredients are widely used in healing varied types of burn wounds. Hence, increasing accidental cases is estimated to propel the demand for these products, that is projected to lead to market growth.
Cancer is widely caused disorder which leads to death. As per the WHO, cancer is the main reason of mortality worldwide and around one in six deaths occurred owing to cancer. Additionally, more than 70 per cent of cancer-related deaths prevailed in middle and low income levels countries. Due to the increasing incidences of chronic disorders, the prolonged hospitalization is increasing along with surgeries which would increase the demand for anti-biofilm wound dressing treatment.
Moreover, as now people are actively participating in sports activities, hence the chances of injuries are also increasing. For example, as per the Stanford Children’s Health, approximately 3.5 million injuries are recorded each year among the pediatric population in the U.S., and approximately 21 per cent of the injuries are traumatic. Besides this, as per the Canadian Institute for Health Information (CIHI), in 2017, more than 17,655 individuals were hospitalized owing to sports regarding injuries. Thus, increasing cases of injuries are witnessed to fuel the demand for global market.
The market is primarily segmented based on mode of mechanism, by application, end-use, and geographic region.
By Mode of Mechanism
Know more about this report: request for sample pages
Based upon mode of mechanism, the global market is categorized into Physical, Biological, and Chemical. Of all, the chemical mode of mechanism segment held a significant share in 2019. The segment is expected to witness major growth over the study period due to the increasing cases of chronic injuries & rising cases of surgeries worldwide. The chemical anti-biofilm wound dressing products have multi actions against biofilm, thereby raising the healing & recovery rate of the chronic wounds. It also minimizes the biofilm burden on both types of wounds along with lowering the risk of getting recontamination with microorganisms.
Based on application, the global anti-biofilm wound dressing market is categorized into Chronic and Acute Wounds. It includes surgical wounds, minor cuts, bites, abrasions & burns, along with severe traumatic lacerations i.e. caused by gunshot injuries. On the other hand, the chronic wounds occurred by endogenous mechanisms owing to the predisposing condition i.e. dermal and epidermal tissue integrity. The chronic wounds are formed by the pressure sores, foot ulcers & leg ulcers, results by venous hypertension or impaired arterial supply and metabolic diseases including diabetes mellitus.
The acute wounds segment held the significant revenue share in 2019. It includes burns & wounds. The rise in the burn injuries cases globally are driving the growth of the segment. Each year, more than 50% of the populace worldwide is at the risk factor of fire-related traumas, of which 90% of the incidents occurred in moderate-to-lower level income countries. According to the World Health Organization, around 1,000,000 people are recorded moderately & severely burnt in every year. Moreover, the primary treatment involves the dressing and prevention of injury from the biofilm formation. Henceforth, the rising patients who are suffering from an acute injury are projected to fuel the segment growth.
Based on end use, the global market is categorized into Hospital, Wound Care Centers, Clinics & Others. Hospitals are expected to witness the significant growth rate during the forecast period due to the rising cases of chronic wounds and rising hospitalizations. Additionally, rising cases of diabetic foot & venous leg ulcers are the key factors fueling the growth of the segment. However, the surgical wounds incidents are rising owing to an increase in the surgeries are further propelling the growth of the segment.
Based on the region, the global anti-biofilm wound dressing market has been categorized into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Among all, North America has dominated the market in 2019. The rising cases of the road accidents, sports related injuries, and presence of big players in this region are the factors which are fueling the regional market growth. Additionally, the presence of good healthcare facilities and suitable reimbursement policies also favoring the market.
In the Asia Pacific, the market is projected to achieve fastest growth at the forecasted period owing to the presence of various developing countries including China, Japan & India are witnessed to drive the regional market. Additionally, the expanding medical tourism industry in these regions is further contributing to concerned product demand. For example, as per the report of the Export Health Services by Directorate General of Commercial Intelligence & Statistics of India, in 2016, India had 58,300 medical tourists.
In Latin America, the market is witnessed to grow at a significant rate during the gauge period. The presence of emerging economies including Mexico & Brazil, is witnessed to boosts the regional market growth. The presence of advanced therapy options at lower costs in Latin America is making a suitable location for the medical tourism. Additionally, governments of this countries are indulged in the improvement of healthcare infrastructure. Henceforth, all these factors are projected to boosts the region’s market growth.
Key players operating in the global market are concentrating on the joint ventures, collaborations, regional expansion and investments for fortifying their worldwide impressions by entering into undiscovered markets. Additionally, the companies are also focusing on the research and development to develop technologically advanced products to sustain in the competition.
Imbed Biosciences Inc. has been rewarded with a USD 1.5 million & National Institute for Arthritis grant for the research and development of the bioresorbable wound dressing incorporated with gallium & silver metal ions that is bactericidal in nature. This anti-biofilm dressing research program is built by the clinical success of Microlyte silver dressing to be utilized in the treatment of chronic wounds patients. Moreover, previously, in November 2017, The National Biofilms Innovation Centre (NBIC) has been funded with the EUR 12.5 million with the rationale of prevention, detection, & management of engineered biofilms. Some of the major players operating the global market include Urgo Medical, ConvaTec, Coloplast, Smith & Nephew PLC, 3M, Monarch Labs, Mega Pharma (Pvt) Ltd., BioMonde, B. Braun Melsungen AG, Mölnlycke Healthcare, Lohmann & Rauscher & Arobella Medical.